Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
oc-000459 (8 trials)
Asthma (Phase 2)
Eosinophilic Esophagitis (Phase 2)
Esophagitis (Phase 2)
Rhinitis (Phase 2)
Rhinitis, Allergic (Phase 2)
Trials (8 total)
Trial APIs (1 total)